X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Marico Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs MARICO LTD - Comparison Results

MARICO LTD 
   Change

Marico derives 72% of its domestic revenues from edible oil and 20% from hair oils. It has two well-known domestic brands Parachute and Saffola and has acquired a clutch of international personal care brands such as 'Camelia', 'Aromatic' and 'Magnoli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES MARICO LTD AMAR REMEDIES/
MARICO LTD
 
P/E (TTM) x -0.5 50.8 - View Chart
P/BV x 0.1 19.6 0.3% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 AMAR REMEDIES   MARICO LTD
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
MARICO LTD
Mar-16
AMAR REMEDIES/
MARICO LTD
5-Yr Chart
Click to enlarge
High Rs164468 35.0%   
Low Rs86208 41.4%   
Sales per share (Unadj.) Rs261.647.5 550.4%  
Earnings per share (Unadj.) Rs17.45.6 309.6%  
Cash flow per share (Unadj.) Rs22.36.4 347.8%  
Dividends per share (Unadj.) Rs04.25 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs100.716.3 619.8%  
Shares outstanding (eoy) m26.161,290.17 2.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.57.1 6.7%   
Avg P/E ratio x7.260.2 11.9%  
P/CF ratio (eoy) x5.652.8 10.6%  
Price / Book Value ratio x1.220.8 6.0%  
Dividend payout %075.7 0.0%   
Avg Mkt Cap Rs m3,270436,077 0.7%   
No. of employees `000NA2.5 0.0%   
Total wages/salary Rs m1633,639 4.5%   
Avg. sales/employee Rs ThNM24,916.9-  
Avg. wages/employee Rs ThNM1,478.7-  
Avg. net profit/employee Rs ThNM2,945.1-  
INCOME DATA
Net Sales Rs m6,84461,320 11.2%  
Other income Rs m21934 2.2%   
Total revenues Rs m6,86562,254 11.0%   
Gross profit Rs m1,13110,625 10.6%  
Depreciation Rs m1281,018 12.6%   
Interest Rs m398203 196.4%   
Profit before tax Rs m62610,338 6.1%   
Minority Interest Rs m0-118 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1212,971 4.1%   
Profit after tax Rs m4557,248 6.3%  
Gross profit margin %16.517.3 95.4%  
Effective tax rate %19.328.7 67.2%   
Net profit margin %6.611.8 56.2%  
BALANCE SHEET DATA
Current assets Rs m4,90421,146 23.2%   
Current liabilities Rs m3,58113,001 27.5%   
Net working cap to sales %19.313.3 145.5%  
Current ratio x1.41.6 84.2%  
Inventory Days Days12455 225.5%  
Debtors Days Days10015 666.6%  
Net fixed assets Rs m1,6895,826 29.0%   
Share capital Rs m2621,290 20.3%   
"Free" reserves Rs m2,35818,574 12.7%   
Net worth Rs m2,63520,968 12.6%   
Long term debt Rs m5074 12,365.9%   
Total assets Rs m6,86234,333 20.0%  
Interest coverage x2.652.0 4.9%   
Debt to equity ratio x0.20 98,403.1%  
Sales to assets ratio x1.01.8 55.8%   
Return on assets %12.421.7 57.3%  
Return on equity %17.334.6 50.0%  
Return on capital %31.049.7 62.4%  
Exports to sales %4.02.9 139.8%   
Imports to sales %03.6 0.0%   
Exports (fob) Rs m2731,749 15.6%   
Imports (cif) Rs mNA2,225 0.0%   
Fx inflow Rs m2732,933 9.3%   
Fx outflow Rs m22,463 0.1%   
Net fx Rs m271470 57.7%   
CASH FLOW
From Operations Rs m-3138,326 -3.8%  
From Investments Rs m-489-2,357 20.7%  
From Financial Activity Rs m769-5,799 -13.3%  
Net Cashflow Rs m-33171 -19.1%  

Share Holding

Indian Promoters % 25.5 59.6 42.8%  
Foreign collaborators % 0.0 0.1 -  
Indian inst/Mut Fund % 9.2 2.6 353.8%  
FIIs % 0.0 31.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 6.7 974.6%  
Shareholders   13,061 37,128 35.2%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GODREJ INDUSTRIES  JYOTHY LABS  P&G HYGIENE  GILLETTE INDIA  BATA INDIA  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

Aug 9, 2017

While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

Marico: Margin Expansion Drives Profit Growth (Quarterly Results Update - Detailed)

Nov 28, 2016

Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - GODREJ CONSUMER COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS